Steven R. Zeldenrust

21.4k citations

165 papers · 9.9k indexed · 4 hit papers · h-index 47

Molecular Biology top 0.5%
Hematology top 0.05%
Oncology top 0.5%
Genetics top 0.5%
Nephrology top 0.5%

Co-authors: Morie A. Gertz Angela Dispenzieri Robert A. Kyle Martha Q. Lacy S. Vincent Rajkumar John A. Lust Shaji Kumar Suzanne R. Hayman
Topics: Amyloidosis: Diagnosis, Treatment, Outcomes (94 papers)Multiple Myeloma Research and Treatments (71 papers)Protein Degradation and Inhibitors (26 papers)
Cited by: Hematology Nephrology Genetics
Journals: Journal of Clinical Oncology Blood Journal of the American College of Cardiology
Partner nations: United States Italy United Kingdom

In The Last Decade

Steven R. Zeldenrust

162 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved survival in multiple myeloma and the impact of novel therapies

2007 1.7k citations Shaji Kumar, S. Vincent Rajkumar et al. Blood profile →
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

2013 957 citations Shaji Kumar, Angela Dispenzieri et al. profile →
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

2004 639 citations Angela Dispenzieri, Morie A. Gertz et al. Journal of Clinical Oncology profile →
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

2016 475 citations Martha Grogan, Christopher G. Scott et al. profile →

Peers

Countries citing papers authored by Steven R. Zeldenrust

Since Specialization

Citations

This map shows the geographic impact of Steven R. Zeldenrust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Zeldenrust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Zeldenrust more than expected).

Fields of papers citing papers by Steven R. Zeldenrust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Zeldenrust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Zeldenrust. The network helps show where Steven R. Zeldenrust may publish in the future.

Co-authorship network of co-authors of Steven R. Zeldenrust

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Zeldenrust. A scholar is included among the top collaborators of Steven R. Zeldenrust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Zeldenrust. Steven R. Zeldenrust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Substratification of patients with newly diagnosed standard‐risk multiple myeloma 2019 ·British Journal of Haematology ·Moritz Binder,S. Vincent Rajkumar,Rhett P. Ketterling,Angela Dispenzieri,Martha Q. Lacy,Morie A. Gertz,Francis K. Buadi,Suzanne R. Hayman,Yi L. Hwa,Steven R. Zeldenrust,John A. Lust,Stephen J. Russell,Nelson Leung,Prashant Kapoor,Ronald S. Go,Wilson I. Gonsalves,Robert A. Kyle,Shaji Kumar	10
2	Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry 2016 ·Blood ·Taxiarchis Kourelis,Surendra Dasari,Jason D. Theis,Marina Ramı́rez-Alvarado,Paul J. Kurtin,Morie A. Gertz,Steven R. Zeldenrust,Roman M. Zenka,Ahmet Doǧan,Angela Dispenzieri	106
3	The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation 2015 ·Nephrology Dialysis Transplantation ·Nelson Leung,Shaji Kumar,Siobhán Glavey,Angela Dispenzieri,Martha Q. Lacy,Francis K. Buadi,Suzanne R. Hayman,David Dingli,Prashant Kapoor,Steven R. Zeldenrust,Stephen J. Russell,John A. Lust,William J. Hogan,S. Vincent Rajkumar,Dennis A. Gastineau,Taxiarchis Kourelis,Yi Lin,Wilson I. Gonsalves,Ronald S. Go,Morie A. Gertz	22
4	Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis 2014 ·The American Journal of Cardiology ·Nowell M. Fine,Adelaide M. Arruda‐Olson,Angela Dispenzieri,Steven R. Zeldenrust,Morie A. Gertz,Robert A. Kyle,Paul Swiecicki,Christopher G. Scott,Martha Grogan	105
5	Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics 2014 ·Haematologica ·Julie A. Vrana,Jason D. Theis,Surendra Dasari,Oana Madalina Mereuta,Angela Dispenzieri,Steven R. Zeldenrust,MA Gertz,Paul J. Kurtin,Karen L. Grogg,Ahmet Doǧan	135
6	Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma 2013 ·Journal of Clinical Oncology ·Prashant Kapoor,Shaji Kumar,Angela Dispenzieri,Martha Q. Lacy,Francis K. Buadi,David Dingli,Stephen J. Russell,Suzanne R. Hayman,Thomas E. Witzig,John A. Lust,Nelson Leung,Yi Lin,Steven R. Zeldenrust,Arleigh McCurdy,Philip R. Greipp,Robert A. Kyle,S. Vincent Rajkumar,Morie A. Gertz	120
7	Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome 2013 ·Blood ·Angela Dispenzieri,Morie A. Gertz,(unknown),Martha Q. Lacy,Francis K. Buadi,Suzanne R. Hayman,Nelson Leung,Arleigh McCurdy,Yi L. Hwa,(unknown),David Dingli,Prashant Kapoor,Steven R. Zeldenrust,John A. Lust,Stephen J. Russell,S. Vincent Rajkumar,Shaji Kumar	2
8	Genotype, echocardiography, and survival in familial transthyretin amyloidosis 2013 ·Amyloid ·Adelaide M. Arruda‐Olson,Steven R. Zeldenrust,Angela Dispenzieri,Morie A. Gertz,Fletcher A. Miller,Suzette J. Bielinski,Kyle W. Klarich,Christopher G. Scott,Martha Grogan	31
9	The diflunisal trial: update on study drug tolerance and disease progression 2011 ·Amyloid ·John L. Berk,P. James B. Dyck,Laura Obici,Steven R. Zeldenrust,Yoshiki Sekijima,Takayoshi Yamashita,Yukio Ando,Shu‐ichi Ikeda,Peter D. Gorevic,Giampaolo Merlini,Jeffery W. Kelly,M Skinner,Alice Bisbee,Ole B. Suhr,(unknown)	26
10	Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial 2011 ·American Journal of Hematology ·Shaji Kumar,Martha Q. Lacy,Suzanne R. Hayman,Keith Stewart,Francis K. Buadi,Jacob B. Allred,Kristina Laumann,Philip R. Greipp,John A. Lust,Morie A. Gertz,Steven R. Zeldenrust,P. Leif Bergsagel,Craig B. Reeder,Thomas E. Witzig,Rafaël Fonseca,Stephen J. Russell,Joseph Mıkhael,David Dingli,S. Vincent Rajkumar,Angela Dispenzieri	44
11	Report and recommendations from the 1st International Workshop on the Hereditary Renal Amyloidoses, FAP Symposium, London, 2008 2010 ·Amyloid ·Arie J. Stangou,Luísa Lobato,Steven R. Zeldenrust,Bernard Portmann,R. P. Linke,G. F. Otto,H Wilczek,Ole B. Suhr,David Azoulay,Gilles Grateau,Maria M. Picken,Justin O’Grady,B.-G. Ericzon,Nigel Heaton,M D Benson	5
12	Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score 2010 ·Mayo Clinic Proceedings ·Shaji Kumar,Morie A. Gertz,Martha Q. Lacy,David Dingli,Suzanne R. Hayman,Francis K. Buadi,(unknown),Steven R. Zeldenrust,Nelson Leung,Philip R. Greipp,John A. Lust,Stephen J. Russell,Robert A. Kyle,S. Vincent Rajkumar,Angela Dispenzieri	124
13	Mass Spectrometric–Based Proteomic Analysis of Amyloid Neuropathy Type in Nerve Tissue 2010 ·Archives of Neurology ·Christopher J. Klein,Julie A. Vrana,Jason D. Theis,P. James B. Dyck,Robert J. Spinner,Michelle L. Mauermann,H. Robert Bergen,Steven R. Zeldenrust,Ahmet Doǧan	91
14	Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney 2009 ·Nephrology Dialysis Transplantation ·Morie A. Gertz,Nelson Leung,M. Q. Lacy,Angela Dispenzieri,Steven R. Zeldenrust,S. R. Hayman,Francis K. Buadi,(unknown),Philip R. Greipp,Shaji Kumar,John A. Lust,S. Vincent Rajkumar,Stephen J. Russell,T. E. Witzig	82
15	Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component 2009 ·Mayo Clinic Proceedings ·John A. Lust,Martha Q. Lacy,Steven R. Zeldenrust,Angela Dispenzieri,Morie A. Gertz,Thomas E. Witzig,Shaji Kumar,Suzanne R. Hayman,Stephen J. Russell,Francis K. Buadi,Susan Geyer,Megan E. Campbell,Robert A. Kyle,S. Vincent Rajkumar,Philip R. Greipp,Michael Kline,Yuning Xiong,Laurie L. Moon‐Tasson,Kathleen A. Donovan	196
16	Induction of Heme Oxygenase-1 and Ferritin in the Kidney in Warm Antibody Hemolytic Anemia 2008 ·American Journal of Kidney Diseases ·Fernando C. Fervenza,Anthony J. Croatt,Camila Matzenbacher Bittar,David Rosenthal,Donna J. Lager,Nelson Leung,Steven R. Zeldenrust,Karl A. Nath	28
17	Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement 2007 ·Mayo Clinic Proceedings ·Angela Dispenzieri,S. Vincent Rajkumar,Morie A. Gertz,(unknown),Robert A. Kyle,Philip R. Greipp,(unknown),(unknown),Stephen J. Russell,Suzanne R. Hayman,Shaji Kumar,Steven R. Zeldenrust,Rafaël Fonseca,P. Leif Bergsagel,(unknown),A. Keith Stewart,Vivek Roy,Robert J. Dalton	113
18	Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review 2006 ·Journal of the Peripheral Nervous System ·Shafeeq Ladha,P. James B. Dyck,Robert J. Spinner,Domingo G. Pérez,Steven R. Zeldenrust,Kimberly K. Amrami,Alan Solomon,Christopher J. Klein	19
19	An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum 2003 ·Amyloid ·H. Robert Bergen,Steven R. Zeldenrust,Stephen Naylor	22
20	Orthotopic liver transplantation for hereditary fibrinogen amyloidosis 2003 ·Transplantation ·Steven R. Zeldenrust,Morie A. Gertz,Tomoyuki Uemichi,Jóhannes Björnsson,Rudolf J. Wiesner,Tobias Schwab,M D Benson	36

About Steven R. Zeldenrust

Steven R. Zeldenrust is a scholar working on Hematology, Nephrology and Genetics, having authored 165 papers that have together received 9.9k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (94 papers), Multiple Myeloma Research and Treatments (71 papers) and Protein Degradation and Inhibitors (26 papers). The work is most often cited by research in Hematology (5.1k citations), Nephrology (1.3k citations) and Genetics (1.6k citations). Steven R. Zeldenrust has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Morie A. Gertz, Angela Dispenzieri, Robert A. Kyle, Martha Q. Lacy, S. Vincent Rajkumar, John A. Lust, Shaji Kumar, Suzanne R. Hayman, Stephen J. Russell and Francis K. Buadi. Their work appears in journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact